skip to main content
Primo Advanced Search
Primo Advanced Search Query Term
Primo Advanced Search Query Term
Primo Advanced Search Query Term
Primo Advanced Search prefilters
Resultados 1 2 3 4 5 next page
Result Number Material Type Add to My Shelf Action Record Details and Options
1
Leukemic Stem Cells: A Review
Material Type:
Artigo
Adicionar ao Meu Espaço

Leukemic Stem Cells: A Review

O'Brien, J. A. ; Rizzieri, D. A.

Cancer investigation, 2013-05, Vol.31 (4), p.215-220 [Periódico revisado por pares]

New York, NY: Informa Healthcare

Texto completo disponível

2
Prognostic factors for outcomes in allogeneic transplantation for CML in the imatinib era: a CIBMTR analysis
Material Type:
Artigo
Adicionar ao Meu Espaço

Prognostic factors for outcomes in allogeneic transplantation for CML in the imatinib era: a CIBMTR analysis

KHOURY, H. J ; KUKREJA, M ; GALE, R. P ; MARKS, D. I ; MCCARTHY, P. L ; WOOLFREY, A ; SZER, J ; GIRALT, S. A ; MAZIARZ, R. T ; CORTES, J ; HOROWITZ, M. M ; LEE, S. J ; GOLDMAN, J. M ; WANG, T ; HALTER, J ; ARORA, M ; GUPTA, V ; RIZZIERI, D. A ; GEORGE, B ; KEATING, A

Bone marrow transplantation (Basingstoke), 2012-06, Vol.47 (6), p.810-816 [Periódico revisado por pares]

Basingstoke: Nature Publishing Group

Texto completo disponível

3
The interleukin-3 receptor alpha chain is a unique marker for human acute myelogenous leukemia, stem cells
Material Type:
Artigo
Adicionar ao Meu Espaço

The interleukin-3 receptor alpha chain is a unique marker for human acute myelogenous leukemia, stem cells

JORDAN, C. T ; UPCHURCH, D ; LUGER, S. M ; PHILLIPS, G. L ; SZILVASSY, S. J ; GUZMAN, M. L ; HOWARD, D. S ; PETTIGREW, A. L ; MEYERROSE, T ; ROSSI, R ; GRIMES, B ; RIZZIERI, D. A

Leukemia, 2000-10, Vol.14 (10), p.1777-1784 [Periódico revisado por pares]

London: Nature Publishing

Texto completo disponível

4
The genetic landscape of mutations in Burkitt lymphoma
Material Type:
Artigo
Adicionar ao Meu Espaço

The genetic landscape of mutations in Burkitt lymphoma

LOVE, Cassandra ; ZHEN SUN ; LUGAR, Patricia L ; RIZZIERI, David A ; LAGOO, Anand S ; BERNAL-MIZRACHI, Leon ; MANN, Karen P ; FLOWERS, Christopher R ; NARESH, Kikkeri N ; EVENS, Andrew M ; CHADBURN, Amy ; GORDON, Leo I ; JIMA, Dereje ; CZADER, Magdalena B ; GILL, Javed I ; HSI, Eric D ; GREENOUGH, Adrienne ; MOFFITT, Andrea B ; MCKINNEY, Matthew ; BANERJEE, Anjishnu ; GRUBOR, Vladimir ; LEVY, Shawn ; DUNSON, David B ; GUOJIE LI ; DAVE, Sandeep S ; ZHANG, Jenny ; MILES, Rodney ; RICHARDS, Kristy L ; DUNPHY, Cherie H ; CHOI, William W. L ; SRIVASTAVA, Gopesh

Nature genetics, 2012-12, Vol.44 (12), p.1321-1325 [Periódico revisado por pares]

New York, NY: Nature Publishing Group

Texto completo disponível

5
Differential impact of inhibitory and activating Killer Ig-Like Receptors (KIR) on high-risk patients with myeloid and lymphoid malignancies undergoing reduced intensity transplantation from haploidentical related donors
Material Type:
Artigo
Adicionar ao Meu Espaço

Differential impact of inhibitory and activating Killer Ig-Like Receptors (KIR) on high-risk patients with myeloid and lymphoid malignancies undergoing reduced intensity transplantation from haploidentical related donors

CHEN, D.-F ; PRASAD, V. K ; LONG, G. D ; YANG, Y ; CHAO, N. J ; RIZZIERI, D. A ; BROADWATER, G ; REINSMOEN, N. L ; DEOLIVEIRA, A ; CLARK, A ; SULLIVAN, K. M ; CHUTE, J. P ; HORWITZ, M. E ; GASPARETTO, C

Bone marrow transplantation (Basingstoke), 2012-06, Vol.47 (6), p.817-823 [Periódico revisado por pares]

Basingstoke: Nature Publishing Group

Texto completo disponível

6
Apolipoprotein E genotype as a determinant of survival in chronic lymphocytic leukemia
Material Type:
Artigo
Adicionar ao Meu Espaço

Apolipoprotein E genotype as a determinant of survival in chronic lymphocytic leukemia

WEINBERG, J. B ; VOLKHEIMER, A. D ; RIZZIERI, D. A ; LEVESQUE, M. C ; DEKROON, R ; STRITTMATTER, W. J ; MIHOVILOVIC, M ; JIANG, N ; CHEN, Y ; BOND, K ; MOORE, J. O ; GOCKERMAN, J. P ; DIEHL, L. F ; DE CASTRO, C. M

Leukemia, 2008-12, Vol.22 (12), p.2184-2192 [Periódico revisado por pares]

Avenel, NJ: Nature Publishing Group

Texto completo disponível

7
Response and toxicity of donor lymphocyte infusions following T-cell depleted non-myeloablative allogeneic hematopoietic SCT from 3-6 6 HLA matched donors
Material Type:
Artigo
Adicionar ao Meu Espaço

Response and toxicity of donor lymphocyte infusions following T-cell depleted non-myeloablative allogeneic hematopoietic SCT from 3-6 6 HLA matched donors

RIZZIERI, Da ; DEV, P ; LONG, G. D ; GASPARETTO, C ; SULLIVAN, K. M ; HORWITZ, M. I ; CHUTE, J ; CHAO, N. J

Bone marrow transplantation (Basingstoke), 2009-02, Vol.43 (4), p.327-333 [Periódico revisado por pares]

Basingstoke: Nature Publishing Group

Texto completo disponível

8
Hedgehog signalling is essential for maintenance of cancer stem cells in myeloid leukaemia
Material Type:
Artigo
Adicionar ao Meu Espaço

Hedgehog signalling is essential for maintenance of cancer stem cells in myeloid leukaemia

Chen, Alan ; Munchhof, Michael ; VanArsdale, Todd ; Kwon, Hyog Young ; Beachy, Philip A ; Chute, John P ; Blum, Jordan ; Kim, Jynho ; Zhao, Chen ; Fereshteh, Mark ; Reya, Tannishtha ; Rizzieri, David ; Jamieson, Catriona H ; Abrahamsson, Annelie

Nature, 2009-04, Vol.458 (7239), p.776-779 [Periódico revisado por pares]

London: Nature Publishing Group

Texto completo disponível

9
Early post transplant (F-18) 2-fluoro-2-deoxyglucose positron emission tomography does not predict outcome for patients undergoing auto-SCT in non-Hodgkin and Hodgkin lymphoma
Material Type:
Artigo
Adicionar ao Meu Espaço

Early post transplant (F-18) 2-fluoro-2-deoxyglucose positron emission tomography does not predict outcome for patients undergoing auto-SCT in non-Hodgkin and Hodgkin lymphoma

PALMER, J ; GOGGINS, T ; BROADWATER, G ; CHAO, N ; HORWITZ, M ; BEAVEN, A ; SULLIVAN, K ; COLEMAN, R. E ; RIZZIERI, D

Bone marrow transplantation (Basingstoke), 2011-06, Vol.46 (6), p.847-851 [Periódico revisado por pares]

Basingstoke: Nature Publishing Group

Texto completo disponível

10
A Phase I Study of Arsenic Trioxide (Trisenox), Ascorbic Acid, and Bortezomib (Velcade) Combination Therapy in Patients With Relapsed/Refractory Multiple Myeloma
Material Type:
Artigo
Adicionar ao Meu Espaço

A Phase I Study of Arsenic Trioxide (Trisenox), Ascorbic Acid, and Bortezomib (Velcade) Combination Therapy in Patients With Relapsed/Refractory Multiple Myeloma

Held, Lauren A. ; Rizzieri, David ; Long, Gwynn D. ; Gockerman, Jon P. ; Diehl, Louis F. ; Castro, Carlos M. de ; Moore, Joseph O. ; Horwitz, Mitchell E. ; Chao, Nelson J. ; Gasparetto, Cristina

Cancer investigation, 2013-03, Vol.31 (3), p.172-176 [Periódico revisado por pares]

New York, NY: Informa Healthcare

Texto completo disponível

Resultados 1 2 3 4 5 next page

Personalize Seus Resultados

  1. Editar

Refine Search Results

Expandir Meus Resultados

  1.   

Data de Publicação 

De até
  1. Antes de2003  (4)
  2. 2003Até2005  (6)
  3. 2006Até2008  (18)
  4. 2009Até2012  (23)
  5. Após 2012  (8)
  6. Mais opções open sub menu

Buscando em bases de dados remotas. Favor aguardar.